2021
DOI: 10.1590/0102-311x00277420
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Since the first recorded case of COVID-19 on February 26, 2020, Brazil has seen an exponential growth in the number of cases and deaths. The national testing approach has been insufficient to correctly use this tool in the support of containing the epidemic in the country. In this communication, we discuss efforts and challenges to scale-up COVID-19 testing at the Brazilian Unified National Health System (SUS). This communication presents the initial results of the research project created to investigate the p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0
5

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(29 citation statements)
references
References 2 publications
(1 reference statement)
0
24
0
5
Order By: Relevance
“…In the present study we use correlation data, thus, it was not possible to unveil if the large number of RT-qPCR tests in Macaé, during early stages of the disease, in fact, led to a reduction in ascertainment bias when compared to the rest of the state, since there is a possibility that the mobility restrictions by the municipality also played a role. However, mobility restrictions were performed all over the state (and throughout the country), and thus, restriction measures alone cannot explain the lowest death rates in Macaé, compared to the rest of the state or the country 6 , 9 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the present study we use correlation data, thus, it was not possible to unveil if the large number of RT-qPCR tests in Macaé, during early stages of the disease, in fact, led to a reduction in ascertainment bias when compared to the rest of the state, since there is a possibility that the mobility restrictions by the municipality also played a role. However, mobility restrictions were performed all over the state (and throughout the country), and thus, restriction measures alone cannot explain the lowest death rates in Macaé, compared to the rest of the state or the country 6 , 9 .…”
Section: Discussionmentioning
confidence: 99%
“…Previous work indicated that the best strategy to overcome the disease is through large-scale testing, enabling a rapid diagnosis, and isolation of infected subjects, to halt viral transmission 7 , 8 . The absence of a nationally coordinated testing response during the first semester of 2020, urged for the action of public health actors, universities, local health authorities and hospitals, together with private corporations and banks, to increase test numbers 9 . In this context, the city of Macaé, located in the interior of the state of Rio de Janeiro capital and approximately 200 km from Rio de Janeiro city, adopted a comprehensive molecular (PCR) testing strategy followed by rapid isolation of positive individuals for COVID-19.…”
Section: Introductionmentioning
confidence: 99%
“…The number of new cases in Brazil is likely to be highly underestimated. As Kameda and collaborators [ 21 ] pointed out, the national testing approach has not been adequate in the country, primarily due to a shortage of tests and reagents caused by a lack of coordination and anticipation of reagent purchasing. Also, there has been fragmented funding and distribution of tests throughout the country.…”
Section: Discussionmentioning
confidence: 99%
“…The main reason for this was an initial shortage of tests and reagents due both to the increase in global demand and the lack of coordination of reagent purchases by the country, which forced the federal government to prioritize testing in the public subsector for symptomatic patients who were hospitalized only. Brazil was eventually able to circumvent this issue, but it still faces a dependency on the importation of diagnostic components, as well as inequalities between the public and the private sector regarding the funding and distribution of tests [53].…”
Section: Brazil's Healthcare Systemmentioning
confidence: 99%